Stemtech (STEK) Receivables - Net (2021 - 2025)

Stemtech's (STEK) quarterly Receivables - Net came in at $326487.0 in Q3 2025, down 6.03% quarter-over-quarter from $347445.0 in Q2 2025.

Stemtech (STEK) Receivables - Net (2021 - 2025) Analysis & Trends

Stemtech has disclosed Receivables - Net across 5 years of filings, most recently posting $326487.0 for Q3 2025.

  • Receivables - Net for Q3 2025 came in at $326487.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $326487.0 (changed N/A YoY), and the FY2024 annual result was $269749.0, up 338.66% from the prior year.
  • Receivables - Net came in at $326487.0 for Q3 2025 at Stemtech, down from $347445.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $347445.0 in Q2 2025 to a low of $10720.0 in Q4 2021.
  • The 5-year median for Receivables - Net is $50624.0 (2022), against an average of $117985.6.
  • Across the five-year window, Receivables - Net decreased 17.58% in 2023 and jumped 895.14% in 2024, its largest moves.
  • Stemtech's Receivables - Net stood at $10720.0 in 2021, then jumped by 224.32% to $34767.0 in 2022, then jumped by 76.87% to $61494.0 in 2023, then jumped by 338.66% to $269749.0 in 2024, then rose by 21.03% to $326487.0 in 2025.
  • The last three Receivables - Net figures came in at $326487.0 (Q3 2025), $347445.0 (Q2 2025), and $260307.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Stemtech - - 354,677.00

Historic Data

Download Data
DateValue
Sep 30, 2025 326,487.00
Sep 30, 2025 326,487.00
Jun 30, 2025 347,445.00
Jun 30, 2025 347,445.00
Mar 31, 2025 260,307.00
Mar 31, 2025 260,307.00
Dec 31, 2024 269,749.00
Dec 31, 2024 269,749.00
Jun 30, 2024 230,575.00
Jun 30, 2024 230,575.00
Mar 31, 2024 116,704.00
Mar 31, 2024 116,704.00
Dec 31, 2023 61,494.00
Dec 31, 2023 61,494.00
Sep 30, 2023 102,647.00
Sep 30, 2023 102,647.00
Jun 30, 2023 23,170.00
Jun 30, 2023 23,170.00
Mar 31, 2023 12,535.00
Mar 31, 2023 12,535.00